Suven Life Sciences
- All
- News
- Videos
-
Suven Life Sciences Surges On Announcing Phase 3 Trial For Alzheimer's Drug
Shares of drug maker Suven Life Sciences rose as much as 10.65 per cent to hit an intraday high of Rs 87.80.
-
Suven Life Shares Rise As Firm Gets Patents For Neuro-Degenerative Drug
Suven Life Sciences shares were trading 5.36 per cent up at Rs 166 on BSE in the morning trade.
-
Suven Life Gets Patent For Neuro-Degenerative Drug
With the new patents, Suven has a total of 20 granted patent from Eurasia and 6 from Norway.
-
Sunil Hitech, Cera Sanitaryware Among Jay Thakkar's Multibagger Diwali Picks
The stock markets have given good returns in past one year, with the Nifty rising 10 per cent since last Diwali.
-
Suven Life Surges On Getting Patent For Neuro Degenerative Drug
Shares of Suven Life Sciences rose over 5 per cent today as the company has been granted one product patent each by Europe and Israel for a drug used in the treatment of neuro-degenerative diseases.
-
Suven Gets 2 Patents For Molecules Targeting CNS Disorder
The products are useful in the treatment of cognitive impairment associated with neuro-degenerative disorders like Alzheimer's disease, attention-deficient hyperactivity disorder, Huntington's disease, major depressive disorder, Parkinson's and schizophrenia, Suven Life Sciences said.
-
Suven Life Gets Patent For Neuro-Degenerative Drug
Drug firm Suven Life Sciences has been granted a patent each by Canada, Europe and Hong Kong for a drug used in the treatment of neuro-degenerative diseases.
-
Suven Life Sciences Posts 58% Rise In Q1 Profit
Suven Life Sciences on Wednesday reported a 58.1 per cent increase in net profit at Rs 32.57 crore for the fiscal first quarter that ended on June 30, 2016.
-
Suven Life Receives Establishment Inspection Report From USFDA
Drug firm Suven Life Sciences said it has received the Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant near Hyderabad.
-
Suven Life Up Over 3% On Patent For Neuro-Degenerative Drug
Suven Life said it has been granted "one product patent from Europe and two product patents from Eurasia corresponding to New Chemical Entities (NCEs) for treatment of disorders associated with neuro-degenerative diseases".
-
Suven Gets Patent For Neuro Drugs From Canada, Hong Kong
Drug firm Suven Life Sciences has received a patent each from Canada and Hong Kong for molecules to be developed as drugs for treatment of various central nervous system disorders.
-
Suven Life Gets Patents For Neuro-Degenerative Drug
Drug firm Suven Life Sciences has been granted a patent each by Australia, Eurasia, Israel and the US for a drug used in treatment of neuro-degenerative diseases.
-
Suven Life Gets Patent for Neuro-Degenerative Drug, Shares Rise
Suven Life Sciences has been granted a patent each by China, Eurasia and Hong Kong for a drug used in the treatment of neuro-degenerative diseases.
-
Suven Life Gets Patent for Neuro-Degenerative Drug
The patents from Australia and Canada will be valid till 2032 and 2031, respectively, the company added.
-
Suven Life Sciences Posts 45% Fall in Q3 Profit
Drug firm Suven Life Sciences on Friday reported a 45 per cent dip in standalone net profit at Rs 17.71 crore for the fiscal third quarter that ended on December 31, 2015.
-
Suven Life Sciences Surges On Announcing Phase 3 Trial For Alzheimer's Drug
Shares of drug maker Suven Life Sciences rose as much as 10.65 per cent to hit an intraday high of Rs 87.80.
-
Suven Life Shares Rise As Firm Gets Patents For Neuro-Degenerative Drug
Suven Life Sciences shares were trading 5.36 per cent up at Rs 166 on BSE in the morning trade.
-
Suven Life Gets Patent For Neuro-Degenerative Drug
With the new patents, Suven has a total of 20 granted patent from Eurasia and 6 from Norway.
-
Sunil Hitech, Cera Sanitaryware Among Jay Thakkar's Multibagger Diwali Picks
The stock markets have given good returns in past one year, with the Nifty rising 10 per cent since last Diwali.
-
Suven Life Surges On Getting Patent For Neuro Degenerative Drug
Shares of Suven Life Sciences rose over 5 per cent today as the company has been granted one product patent each by Europe and Israel for a drug used in the treatment of neuro-degenerative diseases.
-
Suven Gets 2 Patents For Molecules Targeting CNS Disorder
The products are useful in the treatment of cognitive impairment associated with neuro-degenerative disorders like Alzheimer's disease, attention-deficient hyperactivity disorder, Huntington's disease, major depressive disorder, Parkinson's and schizophrenia, Suven Life Sciences said.
-
Suven Life Gets Patent For Neuro-Degenerative Drug
Drug firm Suven Life Sciences has been granted a patent each by Canada, Europe and Hong Kong for a drug used in the treatment of neuro-degenerative diseases.
-
Suven Life Sciences Posts 58% Rise In Q1 Profit
Suven Life Sciences on Wednesday reported a 58.1 per cent increase in net profit at Rs 32.57 crore for the fiscal first quarter that ended on June 30, 2016.
-
Suven Life Receives Establishment Inspection Report From USFDA
Drug firm Suven Life Sciences said it has received the Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant near Hyderabad.
-
Suven Life Up Over 3% On Patent For Neuro-Degenerative Drug
Suven Life said it has been granted "one product patent from Europe and two product patents from Eurasia corresponding to New Chemical Entities (NCEs) for treatment of disorders associated with neuro-degenerative diseases".
-
Suven Gets Patent For Neuro Drugs From Canada, Hong Kong
Drug firm Suven Life Sciences has received a patent each from Canada and Hong Kong for molecules to be developed as drugs for treatment of various central nervous system disorders.
-
Suven Life Gets Patents For Neuro-Degenerative Drug
Drug firm Suven Life Sciences has been granted a patent each by Australia, Eurasia, Israel and the US for a drug used in treatment of neuro-degenerative diseases.
-
Suven Life Gets Patent for Neuro-Degenerative Drug, Shares Rise
Suven Life Sciences has been granted a patent each by China, Eurasia and Hong Kong for a drug used in the treatment of neuro-degenerative diseases.
-
Suven Life Gets Patent for Neuro-Degenerative Drug
The patents from Australia and Canada will be valid till 2032 and 2031, respectively, the company added.
-
Suven Life Sciences Posts 45% Fall in Q3 Profit
Drug firm Suven Life Sciences on Friday reported a 45 per cent dip in standalone net profit at Rs 17.71 crore for the fiscal third quarter that ended on December 31, 2015.
